CD274 and nonpapillary renal cell carcinoma: Although the ccRCC TME exhibits disturbances of immunosuppressive MDSCs, M2-macrophages, and Tregs, the induction of inhibitory checkpoint molecules such as PD-L1 on diverse subsets of immune cells is a promising attribute of the use of ICIs in the ccRCC treatment.